Human medicines European public assessment report (EPAR): Levetiracetam ratiopharm, levetiracetam, Date of authorisation: 26/08/2011, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 30 June 2025 - 13:34

Human medicines European public assessment report (EPAR): Levetiracetam ratiopharm, levetiracetam, Date of authorisation: 26/08/2011, Revision: 16, Status: Authorised

Orphan designation: Induced pluripotent stem cells-derived myogenic progenitor cells Treatment of Becker muscular dystrophy, 22/05/2025 Positive

Submitted by Anonymous (not verified) on 30 June 2025 - 13:10

Orphan designation: Induced pluripotent stem cells-derived myogenic progenitor cells Treatment of Becker muscular dystrophy, 22/05/2025 Positive

Real-world evidence framework to support EU regulatory decision-making: 3rd report on the experience gained with regulator-led studies from February 2024 to February 2025

Submitted by Anonymous (not verified) on 30 June 2025 - 13:05

Real-world evidence framework to support EU regulatory decision-making: 3rd report on the experience gained with regulator-led studies from February 2024 to February 2025

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness